
Frances Autorité de la concurrence has cleared Elsan’s acquisition of Hexagone Santé Méditerranée subject to commitments, the regulator reported Monday (March 1).
Elsan operates 120 healthcare facilities (hospitals, clinics, rehabilitation centres) across France offering medical, surgical and obstetric services, follow-up care and rehabilitation, and to a lesser extent, psychiatric care, home hospitalization and cosmetic surgery.
Hexagone Santé Méditerranée (HSM) consists of three healthcare facilities in the Gard département. The facilities mainly provide medical, surgical and obstetric services, as well as cosmetic surgery.
Since the rates for healthcare services paid by the French social security fund to facilities are set at the national level on a per act basis from which healthcare facilities cannot derogate, the merger is not likely to have any effects in this regard, reported the regulator in a statement.
The regulator concluded that following the transaction, Elsan will have significant positions in a number of medical specialities, particularly in the areas around HSM’s facilities.
However a partial transfer, which implies abandoning certain activities, would result in a reduction of the healthcare offering in the areas concerned (Nîmes), to the detriment of patients.
Full Content: Autorite de la Concurrence
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas